Women’s health in Mexico sits at a critical inflection point: it is estimated that only 21 percent of women had a Pap test in the last year and only 15.6 percent had a clinical breast exam with the public system underfunded and at overcapacity. Yet, the women’s health market is projected to grow to nearly US$882 million by 2030—the fastest-growing in North America. This lunch will explore how investment and innovation can bridge gaps in access, standardize care, and unlock opportunities in this rapidly expanding sector.